Article

AAO and ICO collaborate on ophthalmic education initiative

The American Academy of Ophthalmology (AAO) is collaborating with the International Council of Ophthalmology (ICO) to enhance the training and continuing education of ophthalmologists in developing countries.

San Francisco-The American Academy of Ophthalmology (AAO) is collaborating with the International Council of Ophthalmology (ICO) to enhance the training and continuing education of ophthalmologists in developing countries.

The AAO and ICO will send the AAO's Basic and Clinical Science Course (BCSC) in early May to 200 ophthalmology residency training programs at no cost in 61 nations. The BCSC covers all aspects of ophthalmology from basics to specialties.

"The academy is excited to be collaborating with the ICO on the efforts to enhance ophthalmic education internationally," said H. Dunbar Hoskins Jr., MD, executive vice president of the AAO. "Education is at the core of the academy's mission, and providing robust educational offerings to ophthalmologists in developing countries is an important step in helping us to extend that mission internationally."

"We are pleased to collaborate with the academy on this significant effort," said Bruce E. Spivey MD, president of the ICO. "The ICO is dedicated to enhancing ophthalmic education and access to eye care worldwide, but with a particular focus on developing countries. We are happy to help make some of the academy's excellent educational programs available to those who would not otherwise have access. This will not only support training and continuing education of ophthalmologists but also, in the long run, enhance patient care."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.